6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Dyslipidemias in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antropova, NV; Kustikova, IN; Moiseeva, IIa; Rodina, OP; Vodop'ianova, OA | 1 |
1 other study(ies) available for 6-methyl-2-ethyl-3-hydroxypyridine and Dyslipidemias
| Article | Year |
|---|---|
[The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia].
Topics: Animals; Anxiety; Disease Models, Animal; Drug Combinations; Dyslipidemias; Emotions; Flavin Mononucleotide; Inosine Diphosphate; Male; Niacinamide; Picolines; Rats; Succinates | 2014 |